nach oben

Digestive Diseases and Sciences

Erschienen in:

02.02.2021 | UNM CLINICAL CASE CONFERENCES

Cure My Virus: Hematemesis and Melena in a Transplant Recipient

verfasst von: S. Sahni, H. Kassam, N. Yaghooti, A. Birg, D. M. McCarthy

Erschienen in: Digestive Diseases and Sciences | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Excerpt

The gastrointestinal service was consulted to help care for a hemodynamically unstable 45-year-old man with complaints of hematemesis and hematochezia. His history included congenital heart disease requiring cardiac transplantation at age 20, with ongoing immunosuppressive therapy, currently on azathioprine 25 mg, tacrolimus 1.5 mg, and prednisone 5 mg daily. Other prominent comorbidities included diffuse large B cell lymphoma, diabetes mellitus type II, end-stage renal disease (ESRD) requiring hemodialysis, cardiac conduction abnormalities requiring pacemaker placement, atrial fibrillation, and anticoagulation for an intramural cardiac thrombus; he also suffered from recurrent enteric infections with Clostridioides difficile. His surgical history included duodenal and multiple small bowel resections for ischemic injury due to chronic mesenteric vascular insufficiency. At the time of consultation, he had experienced 10–12 bouts of hematochezia with large amounts of bright red blood. Though he reported chronic diarrhea, he denied any abdominal pain, dyspepsia, or weight loss. …

Zuhair M et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol 2019;29:e2034. https://doi.org/10.1002/rmv.2034.CrossRefPubMed

Taylor-Wiedeman J, Sissons JGP, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J General Virol 1991;72:2059–2064. https://doi.org/10.1099/0022-1317-72-9-2059.CrossRef

Fletcher JM, Prentice HG, Grundy JE. Natural killer cell lysis of cytomegalovirus (cmv)-infectedcells correlates with virally induced changes in cell surfacelymphocyte function-associated antigen-3 (lfa-3)expression and not with the cmv-induced down-regulationof cell surface Class I HLA. J Immunol 1998;161:2365–2374PubMed

Reyburn HT, Mandelboim O, Valés-Gómez M, Davis DM, Pazmany L, Strominger JL. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 1997;386:514–517. https://doi.org/10.1038/386514a0.CrossRefPubMed

Chopra KB et al. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation 2003;76:1487–1491. https://doi.org/10.1097/01.TP.0000088668.28950.7C.CrossRefPubMed

Sagedal S et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 2004;66:329–337. https://doi.org/10.1111/j.1523-1755.2004.00735.x.CrossRefPubMed

Streblow D, Orloff S, Nelson J. Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol 2007;19:577–582. https://doi.org/10.1016/j.coi.2007.07.012.CrossRefPubMedPubMedCentral

Grattan MT, Moreno-Cabral C, Starnes VA. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.pdf. JAMA 1989;261:3561–3566CrossRef

Speir E et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265:391–394CrossRef

10.

Melnick JL, Adam E, Debakey ME. Cytomegalovirus and atherosclerosis. Eur Heart J 2014;14:30–38

11.

Harkins L et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002;360:7CrossRef

12.

Shrestha BM, Darby C, Fergusson C, Lord R, Salaman JR, Moore RH. Cytomegalovirus causing acute colonic pseudo-obstruction in a renal transplant recipient. Postgraduate Med J 1996;72:429–430. https://doi.org/10.1136/pgmj.72.849.429.CrossRef

13.

Rotterdam H, Tsang P. Gastrointestinal disease in the immunocompromised patient. Hum Pathol 1994;25:1123–1140. https://doi.org/10.1016/0046-8177(94)90029-9.CrossRefPubMed

14.

Mendez-Eirin E et al. Cumulative incidence of cytomegalovirus infection and disease after heart transplantation in the last decade: effect of preemptive therapy. Transp Proc 2012;44:2660–2662. https://doi.org/10.1016/j.transproceed.2012.09.035.CrossRef

15.

Muldoon J, O’Riordan K, Rao S, Abecassis M. ISCHEMIC COLITIS SECONDARY TO VENOUS THROMBOSIS: A Rare... : Transplantation. Transplantation 1996;61:1651–1653. https://doi.org/10.1097/00007890-199606150-00018.CrossRefPubMed

16.

Roskell DE, Hyde GM, Campbell AP, Jewell DP, Gray W. HIV associated cytomegalovirus colitis as a mimic of inflammatory bowel disease. Gut 1995;37:148–150. https://doi.org/10.1136/gut.37.1.148.CrossRefPubMedPubMedCentral

17.

Beaugerie L et al. Etiology and management of toxic megacolon in patients with human immunodeficiency virus infection. Gastroenterology 1994;107:858–863. https://doi.org/10.1016/0016-5085(94)90137-6.CrossRefPubMed

18.

Diaz-Gonzalez V, Altemose G, Ogorek C, Pina I. Cytomegalovirus infection presenting as an apple-core lesion of the colon. J Heart Lung Transplant 1997;16:1171–1175PubMed

19.

Klauber Enid, Briski Laurence E. Cytomegalovirus colitis in the immunocompetent host: an overview. Scandinavian J Infect Diseases 1998;30:559–564. https://doi.org/10.1080/00365549850161098.CrossRef

20.

Paya C et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004;4:611–620. https://doi.org/10.1111/j.1600-6143.2004.00382.x.CrossRefPubMed

21.

Rasmussen L et al. Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus. J Infect Diseases 1982;145:191–199. https://doi.org/10.1093/infdis/145.2.191.CrossRef

22.

Fisher CE et al. Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients. Transplant Infect Disease 2016;18:372–380. https://doi.org/10.1111/tid.12531.CrossRef

23.

A. Crespo, M. G. F. M. ,. Gómez, M. ,. Monserrat, L. ,. Suarez, F. ,. Rodríguez, J. A. ,. Paniagua, M. J. ,. Cuesta, M. ,. Juffé, A. &. Castro-Beiras, A., “Cytomegalovirus Colitis Mimicking A Colonic Neoplasm or Ischemic Colitis 4 Years After Heart Transplantation,” Transplantation, vol. 66, pp. 1562–1565, 1998, doi: https://doi.org/10.1097/00007890-199812150-00023.

24.

Fan X, Scott L, Qiu S, Raju GS, Shabot M. Colonic coinfection of histoplasma and cytomegalovirus mimicking carcinoma in a patient with HIV/AIDS. Gastrointest Endoscopy 2008;67:977–978. https://doi.org/10.1016/j.gie.2007.11.004.CrossRef

25.

Anderson VM, Greco MA, Recalde AL, Chandwani S, Church JA, Krasinski K. Intestinal cytomegalovirus ganglioneuronitis in children with human immunodeficiency virus infection. Pediatric Pathol 1990;10:167–174. https://doi.org/10.3109/15513819009067105.CrossRef

26.

Burns LJ, Pooley JC, Walsh DJ, Vercellotti GM, Weber ML, Kovacs A. Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins1. Transplantation 1999;67:137–144. https://doi.org/10.1097/00007890-199901150-00023.CrossRefPubMed

27.

Sedmak D, Knight D, Vook N, Waldman J. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 1994;58:1379–1385PubMed

28.

Dieterich DT et al. Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study. J Infect Dis 1993;167:278–282. https://doi.org/10.1093/infdis/167.2.278.CrossRefPubMed

29.

Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol 2014;14:667–685. https://doi.org/10.1038/nri3738.CrossRefPubMed

30.

Åsberg A et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2007;7:2106–2113. https://doi.org/10.1111/j.1600-6143.2007.01910.x.CrossRefPubMed

Titel: Cure My Virus: Hematemesis and Melena in a Transplant Recipient
verfasst von: S. Sahni
H. Kassam
N. Yaghooti
A. Birg
D. M. McCarthy
Publikationsdatum: 02.02.2021
Verlag: Springer US
Erschienen in: Digestive Diseases and Sciences / Ausgabe 3/2021
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-021-06838-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

PLCD1: A Potential Therapeutic Target in the Treatment of Esophageal Squamous Cell Carcinoma?

Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France

All Systems Go: Reconsidering Healthcare Costs in Inflammatory Bowel Disease

Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab

Fecal Microbiota Transplantation in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients: A Pilot Study

Author Spotlight: Giovanna Impellizzeri